首页 » 文章 » 文章详细信息
Journal of Pregnancy Volume 2019 ,2019-07-25
Evaluation of Knowledge and Practice of Pharmacy Professionals regarding the Risk of Medication Use during Pregnancy in Dessie Town, Northeast Ethiopia: A Cross-Sectional Study
Research Article
Abdu Tuha 1 Yilak Gurbie 1 Haftom Gebregergs Hailu 2
Show affiliations
DOI:10.1155/2019/2186841
Received 2019-01-31, accepted for publication 2019-06-23, Published 2019-06-23
PDF
摘要

Background. The developing organism is unique in its responsiveness to drugs and predictability of therapeutic effectiveness based on the adult which can lead to grave consequences in the neonate and child. Moreover, uncertainty about the risks of drug use in pregnancy could result in restrictive attitudes towards prescribing and dispensing medicines and their use. Pharmacists have huge duties to improve medication use, especially among pregnant women. The objective of this study is, hence, to assess the knowledge and practice of pharmacy professionals (PPs) towards the risk of medication use during pregnancy. Methodology. A questionnaire-based cross-sectional study was carried out over practicing community and hospital pharmacy professionals in Dessie town. They were asked about the safety of common drugs during pregnancy. It involves both prescription-only medications (POM) and over-the-counter (OTC) medications. Secondly, they were asked about their practice towards the risk of medication use during pregnancy. Both descriptive and analytical statistics were utilized. For descriptive analysis, results were expressed as numbers, percentages, and mean (± SD and 95% CI). Result. Seventy-six pharmacy professionals in Dessie, Northeast Ethiopia, took part in the study. Most of the respondents (64.5%) believed that amoxicillin is safe in all trimesters. 26 (34.2%) of participants knew that isotretinoin is unsafe for use by pregnant women. About dietary supplements, 32.9% of PPs reported that Vitamin A supplements are safe in all trimesters. There was a significant difference observed for study college and years of experience of the PPs in their score of knowledge test (p=0.020 and p=0.024, respectively). Additionally, there was a difference seen for gender (p=0.030), study college (p=0.036), and working institution (p=0.013) in their advice to pregnant women. Conclusion and Recommendation. Overall, PPs exhibited very low knowledge about drug safety during pregnancy. The absence of obligatory continuing pharmacy education for pharmacists is expected to have negatively affected the level of medication knowledge and consequently the pharmaceutical care services delivered in community and hospital pharmacies. As medication knowledge of PPs is poor, a multitude of strategies (educational, economic, managerial, and regulatory) should be designed by the government, universities, and pharmaceutical associations to improve the pharmacy professionals’ role in the healthcare system by providing them with continuous and up-to-date medication knowledge.

授权许可

Copyright © 2019 Abdu Tuha et al. 2019
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

通讯作者

Abdu Tuha.Department of Pharmacy, College of Medicine and Health Sciences, Wollo University, P.O. Box 1145, Dessie, Ethiopia, wu.edu.et.abdu.tuha@wu.edu.et

推荐引用方式

Abdu Tuha,Yilak Gurbie,Haftom Gebregergs Hailu. Evaluation of Knowledge and Practice of Pharmacy Professionals regarding the Risk of Medication Use during Pregnancy in Dessie Town, Northeast Ethiopia: A Cross-Sectional Study. Journal of Pregnancy ,Vol.2019(2019)

您觉得这篇文章对您有帮助吗?
分享和收藏
0

是否收藏?

参考文献
[1] V. Erdeljić, I. Francetić, K. Makar-Aušperger, R. Likić. et al.(2010). Clinical pharmacology consultation: a better answer to safety issues of drug therapy during pregnancy?. European Journal of Clinical Pharmacology.66(10):1037-1046. DOI: 10.1136/bmjopen-2013-004365.
[2] N. M. Zaki, A. A. Albarraq. (2014). Use, attitudes and knowledge of medications among pregnant women: a Saudi study. Saudi Pharmaceutical Journal.22(5):419-428. DOI: 10.1136/bmjopen-2013-004365.
[3] A. Albassam, A. Awad. (2018). Community pharmacists’ services for women during pregnancy and breast feeding in Kuwait: a cross-sectional study. BMJ Open.8(1):e018980. DOI: 10.1136/bmjopen-2013-004365.
[4] A. C. Vidal, S. K. Murphy, A. P. Murtha, J. M. Schildkraut. et al.(2013). Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. International Journal of Obesity.37(7):907-913. DOI: 10.1136/bmjopen-2013-004365.
[5] K. B. Mensah, K. Opoku-Agyeman, C. Ansah. (2017). Antibiotic use during pregnancy: A retrospective study of prescription patterns and birth outcomes at an antenatal clinic in rural Ghana. Journal of Pharmaceutical Policy and Practice.10(1):24. DOI: 10.1136/bmjopen-2013-004365.
[6] A. A. Nava-Ocampo, G. Koren. (2007). Human teratogens and evidence-based teratogen risk counseling: the motherisk approach. Clinical Obstetrics and Gynecology.50(1):123-131. DOI: 10.1136/bmjopen-2013-004365.
[7] A. Lupattelli, O. Spigset, M. J. Twigg, K. Zagorodnikova. et al.(2014). Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open.4(2):e004365. DOI: 10.1136/bmjopen-2013-004365.
[8] S. F. Widnes. (2013). Drug information in pregnancy. Attitudes and Needs among Pregnant Women and Physicians. DOI: 10.1136/bmjopen-2013-004365.
[9] B. Fisher, N. C. Rose, J. C. Carey. (2008). Principles and practice of teratology for the obstetrician. Clinical Obstetrics and Gynecology.51(1):106-118. DOI: 10.1136/bmjopen-2013-004365.
[10] M. Bullo, S. Tschumi, B. S. Bucher, M. G. Bianchetti. et al.(2012). Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension.60(2):444-450. DOI: 10.1136/bmjopen-2013-004365.
[11] J. P. Baldon, C. J. Correr, A. C. Melchiors, P. Rossignoli. et al.(2006). Community pharmacists' attitudes and knowledge on dispensing drugs to pregnant women. Pharmacy Practice.4(1):38-43. DOI: 10.1136/bmjopen-2013-004365.
[12] Z. Alrabiah, M. N. Al-Arifi, S. M. Alghadeer, S. Wajid. et al.(2017). Knowledge of community pharmacists about the risks of medication use during pregnancy in central region of Saudi Arabia. Saudi Pharmaceutical Journal.25(7):1093-1096. DOI: 10.1136/bmjopen-2013-004365.
[13] B. Thomas, P. Abdulrouf, M. Alhail, W. Elkassem. et al.Knowledge, attitude, perception and experience of pharmacist in qatar towards drug use in pregnancy: a cross-sectional study. .2016:HBPP1830. DOI: 10.1136/bmjopen-2013-004365.
[14] S. Boonyaprapa. Self-care in pregnancy and breastfeeding: views of women and community pharmacists in Thailand, [Doctoral dissertation]. DOI: 10.1136/bmjopen-2013-004365.
[15] P. Salameh, I. Hamdan. (2007). Pharmacy manpower in Lebanon: An exploratory look at work-related satisfaction. Research in Social & Administrative Pharmacy.3(3):336-350. DOI: 10.1136/bmjopen-2013-004365.
[16] A. Kamuhabwa, R. Jalal. (2011). Drug use in pregnancy: Knowledge of drug dispensers and pregnant women in Dar es Salaam, Tanzania. Indian Journal of Pharmacology.43(3):345. DOI: 10.1136/bmjopen-2013-004365.
[17] B. de Tejada. (2014). Antibiotic use and misuse during pregnancy and delivery: benefits and risks. International Journal of Environmental Research and Public Health.11(8):7993-8009. DOI: 10.1136/bmjopen-2013-004365.
[18] B. Farah, M. Mohamad, E. Ahmed M, D. Souraya. et al.(2014). Knowledge, Attitude And Practice of Community Pharmacists Towards Medications Use during Pregnancy. DOI: 10.1136/bmjopen-2013-004365.
[19] F. Bánhidy, R. Lowry, A. E. Czeizel. (2005). Risk and benefit of drug use during pregnancy. International Journal of Medical Sciences.2(3):100-106. DOI: 10.1136/bmjopen-2013-004365.
[20] E. M. Arah. Community pharmacists' medication knowledge: a nation-wide study in Palestine [Doctoral dissertation]. DOI: 10.1136/bmjopen-2013-004365.
[21] E. Kabuluzi. Assessment of risk of drug exposure in early pregnancy in women in a rural community in Malawi, [Doctoral dissertation]. DOI: 10.1136/bmjopen-2013-004365.
[22] I. Zaganjor, A. Sekkarie, B. L. Tsang, J. Williams. et al.(2016). Describing the prevalence of neural tube defects worldwide: A systematic literature review. PLoS ONE.11(4). DOI: 10.1136/bmjopen-2013-004365.
[23] S. Kacew. (1994). Fetal consequences and risks attributed to the use of prescribed and over-the-counter (OTC) preparations during pregnancy. International Journal of Clinical Pharmacology and Therapeutics.32(7):335-343. DOI: 10.1136/bmjopen-2013-004365.
[24] W. S. Webster, J. A. Freeman. (2005). Prescription drugs and pregnancy. Expert Opinion on Pharmacotherapy.4(6):949-961. DOI: 10.1136/bmjopen-2013-004365.
[25] M. Odalović, S. Milanković, L. Holst, H. Nordeng. et al.(2016). Pharmacists counselling of pregnant women: Web-based, comparative study between Serbia and Norway. Midwifery.40:79-86. DOI: 10.1136/bmjopen-2013-004365.
[26] M. Bykhovsky, M. F. Meier, N. A. Mager. (2014). Impact of an online educational program on pharmacy students’ knowledge of folic acid and neural tube defects. Journal of Pharmacy Practice.27(5):513-517. DOI: 10.1136/bmjopen-2013-004365.
文献评价指标
浏览 14次
下载全文 0次
评分次数 0次
用户评分 0.0分
分享 0次